MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing

Stopped early · Not applicable

Conditions studied: Heart Failure

In brief

The purpose of this Clinical investigation is to assess the impact of the Multi Point Pacing (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac Resynchronization Therapy (CRT) after 6 months.

Key facts

Study ID

NCT02006069

Run by

Abbott Medical Devices

People needed

5850

Starts

2013-12-01

Expected to finish

2021-05-30

Last updated by the study team

2023-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets the current ESC Guidelines or ACCF/AHA/HRS Class I or Class IIa indications for CRT implant (including upgrades from single or dual chamber ICDs)
• Must be willing and able to comply with study requirements
• Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form

You may not qualify if…

• Already had a CRT device implanted
• Myocardial Infarction, unstable angina within 40 days prior the enrollment
• Recent cardiac revascularization (PTCA, Stent or CABG) in the 4 weeks prior to enrollment or planned for the 3 months following
• Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) in the 3 months prior the enrollment
• Primary valvular disease
• Atrial Fibrillation:
• Persistent AF at the time of enrollment
• Permanent AF not treated with AV node ablation within 2 weeks from the CRT implant
• History or incidence of Paroxysmal or Persistent AF within 30 days prior the enrollment
• Unable to comply with the follow up schedule
• Less than 18 years of age
• Pregnant or are planning to become pregnant during the duration of the investigation
• Classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 12 months
• Undergone a cardiac transplantation
• Life expectancy < 12 months
• Currently participating in any other clinical investigation

Where it is running

• Cardiovascular Associates of Mesa — Mesa, Arizona, United States
• Phoenix Cardiovascular Research Group — Phoenix, Arizona, United States
• Comprehensive Cardiovascular — Bakersfield, California, United States
• Glendale Adventist Medical Center — Glendale, California, United States
• Scripps Health — La Jolla, California, United States
• Eisenhower Medical Center — Rancho Mirage, California, United States
• Cardiac Rhythm Specialists, Inc. — Reseda, California, United States
• San Diego Cardiac Center — San Diego, California, United States
• Colorado Heart & Vascular, P.C. — Lakewood, Colorado, United States
• Sarasota Memorial Hospital — Sarasota, Florida, United States
• Coliseum Medical Centers — Macon, Georgia, United States
• Redmond Regional Medical Center — Rome, Georgia, United States
• St. Elizabeth Medical Center - South Unit — Edgewood, Kentucky, United States
• Baptist Health Lexington — Lexington, Kentucky, United States
• Brigham and Women's Hospital — Boston, Massachusetts, United States
• McLaren Health Care Corporation — Auburn Hills, Michigan, United States
• MidMichigan Medical Center-Midland — Midland, Michigan, United States
• Munson Medical Center — Traverse City, Michigan, United States
• CHI Health Creighton University Medical Center-Bergan Mercy — Omaha, Nebraska, United States
• Deborah Heart and Lung Center — Browns Mills, New Jersey, United States
• Cardiology Associates of Fairfield County, PC — Haddon Heights, New Jersey, United States
• Samaritan Heart & Vascular Institute - Cardiology Dept. — Corvallis, Oregon, United States
• Lancaster General Hospital — Lancaster, Pennsylvania, United States
• St. Francis Hospital — Greenville, South Carolina, United States
• Heart Center Research, LLC. — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.